Back to today’s briefing

Story perspectives

UK Gyms Surge as GLP-1 Users Seek Muscle Gains

10/26/2025

42 5

Summary

Story summary

In the United Kingdom, GLP-1 (glucagon-like peptide-1) weight-loss drugs can lead to muscle loss, prompting gyms to see rising memberships as users seek training.
Will Orr of The Gym Group calls the trend a growth opportunity for gyms.
Rebecca Passmore of PureGym notes the need to educate staff about these treatments.
With approximately 2.5 million Britons using fat jabs, gyms are offering specialized courses to help members build muscle.

1 of 1

Story summary

In the United Kingdom, GLP-1 (glucagon-like peptide-1) weight-loss drugs can lead to muscle loss, prompting gyms to see rising memberships as users seek training.
Will Orr of The Gym Group calls the trend a growth opportunity for gyms.
Rebecca Passmore of PureGym notes the need to educate staff about these treatments.
With approximately 2.5 million Britons using fat jabs, gyms are offering specialized courses to help members build muscle.